Bright Lisa 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jul 3, 2019
Insider Transaction Report
Form 4
Bright Lisa
CCO & Corp Affairs Officer
Transactions
- Tax Payment
Common Stock
2019-07-01$79.17/sh−530$41,960→ 20,452 total - Sale
Common Stock
2019-07-03$78.66/sh−595$46,803→ 19,857 total
Footnotes (2)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock awards previously granted to the reporting person.
- [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.